Grafton DBM
Recall
|
Blood & Tissue
|
16/02/2023
The Federal Office for Safety in Health Care has been informed by the Dutch authority that sterility problems have occurred with Grafton DBM products from Medtronic (demineralized bone allografts). For more detailed information, please see the following link: www.medtronic.com/graftonrecall. This letter reflects the current information available from BASG.
As soon as further information is available, it will be announced.
Further inquiry note
Page last modified:
16/02/2023